DS

Devansh Sharma

Active Director Director DIN 08882426
DIN 08882426 First appointment Sep 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Devansh Sharma

Data last updated:

Devansh Sharma is a Director at Starway Pharmaceuticals Private Limited (since 2020). The company operates in Trading. Starway Pharmaceuticals Private Limited reported revenue of ₹14.3 Lakh (FY 2025).

DIN 08882426
Primary Designation Director
Industry Trading
First Appointment 17 Sep 2020
Oldest Company Age 6 yrs
Largest company Starway Pharmaceuticals Private Limited · ₹14.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Sep 20202020₹14.3 Lakh (FY 2025)Active

Board colleagues of Devansh Sharma

Directorship timeline

Open interactive timeline →
Starway Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Devansh Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devansh Sharma

Devansh Sharma currently holds 1 directorship: Starway Pharmaceuticals Private Limited (Director, since 17 Sep 2020, revenue ₹14.3 Lakh (FY 2025)).

Devansh Sharma was first appointed on 17 Sep 2020 as Director at Starway Pharmaceuticals Private Limited.

The current boards of Devansh Sharma's companies include Satya Vir Sharma (Starway Pharmaceuticals Private Limited), Seema Sharma (Starway Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available